IMMUNOHEMATOLOGY Flashcards
Gel test was invented in ______ by ________.
1985, Dr. Yves Lapierre
Two antigen/antibody reactions
agglutination and hemolysis
In gel testing, ________ is detected however hemolytic reaction is not detected
hemeagglutination
PARALLEL TESTING
gel test + tube test
immortalized antibody producing cell
hybridoma cell
the antibody producing capacity of hybridoma cell is due to
plasma cell
what is elution
detachment/dissociation of antigen or antibody
IMPORTANCE OF WASHING IN DAT
(1) presence of other unbound antibodies
(2) washing phase
(3) addition of AHG
(4) IgG bridge/ lattice formation
(5) agglutination
Steps in Direct AHG
- Washed patient’s red cell (3x), sensitized in vivo
- Addition of AHG reagent (Coomb’s sera)
- Visual red cell agglutination
Steps in Indirect AHG for human red cells
- Human red cells + Human (patient serum) IgG antibody
- Red cell (in vitro) sensitization
Steps in Indirect AHG for sensitized red cells
- sensitized red cells + Coomb’s sera AHG reagent
- Visual red cell agglutination
Gel test principle
size exclusion chromatography
what gel is used in gel test
dextran polyacrilamide gel
steps/procedure in gel test
- addition of cells
- addition of plasma/serum
- incubation for IgG - body temp
- centrifugation - 5 mins
- results - more than 10 mins
the bigger the size, the ______ the position of cells in the medium
higher
reagent is already pre-dispensed, only add the sample to microtube
a. specific
b. low ionic antiglobulin
c. neutral/plain
a
reagent is not added to the gel, it is added along with the sample in microtube
a. specific
b. low ionic antiglobulin
c. neutral/plain
c
specific for sensitization test. IgG antibodies are detected. AHG reagent is pre-dispensed in gel matrix
a. specific
b. low ionic antiglobulin
c. neutral/plain
b
advantages of using gel testing
- standardization
- stable and well defined agglutination reaction
- decreased sample volume <1mL
- enhanced specificity and sensitivity, no need for cell washing
ABO forward/direct cell typing is and example of
a. specific
b. low ionic antiglobulin
c. neutral/plain
a
INDIRECT/reverse/backward typing is an example of
a. specific
b. low ionic antiglobulin
c. neutral/plain
c
In gel testing, stability is up to _______
3 days
In conventional tube method, stability is up to ____________
an hour
In slide method, stability is up to _______
1 min
If RBC are unagglutinated, it will pass thru the gel and will form __________ at the bottom
cell button
one solid clump, 100 percent antigen reacted with antibodies
a. 3+
b. 4+
c. 1+
d. +/-
b
several large sized clumps, 75 percent antigen reacted with antibodies
a. 3+
b. 4+
c. 1+
d. +/-
a
several medium sized clumps, 50 percent antigen reacted with antibodies
a. 3+
b. 4+
c. 2+
d. +/-
c
several numerous small sized clumps, <25 percent antigen reacted with antibodies
a. 3+
b. 4+
c. 1+
d. +/-
c
weak reaction, very small sized clumps, <25 percent reacted with antibodies
a. 3+
b. 4+
c. 2+
d. +/-
d
RBC on top most part of the cell
a. 3+
b. 4+
c. 2+
d. +/-
b
RBC on upper part of gel matrix
a. 3+
b. 4+
c. 2+
d. +/-
a
RBC is disseminated on gel matrix with most RBC found at the center
a. 3+
b. 4+
c. 2+
d. +/-
c
RBC are found on lower part of the gel
a. 3+
b. 1+
c. 2+
d. +/-
b
RBC found near at the bottom of the tube
a. 3+
b. 4+
c. 2+
d. +/-
d
What antibody cannot agglutinate on its own and is the smallest so it can cross the placenta
IgG
A technique for detecting cell-bound immunoglobulin and is used to detect incomplete antibodies (IgG).
AHG Coomb’s test
acts as a bridge/link so IgG can form lattice sequence
AHG
color of AHG/Coomb’s test
GREEN
Complement binding via classical pathway from MOST - LEAST potent
a. IgG subclass 1, 2, 3
b. IgG subclass 2, 1, 3
c. IgG subclass 3, 1, 2
d. IgG subclass 1, 3, 2
c
natural, big pentamere
a. IgG
b. IgM
b
complete best agglutinating antibody
a. IgG
b. IgM
b
cold-reacting, 1-6 deg
a. IgG
b. IgM
b
saline reactive
a. IgG
b. IgM
b
ABO Antibodies
a. IgG
b. IgM
b
complement binding and is more potent
a. IgG
b. IgM
b
Immune
a. IgG
b. IgM
a
incomplete, coating/sensitizing
a. IgG
b. IgM
a
warm-reacting, 37 deg and is clinically significant
a. IgG
b. IgM
a
albumin/AHG reagent
a. IgG
b. IgM
a
Rh antibodies
a. IgG
b. IgM
a
consists of a pool of rabbit anti-human IgG and mouse monoclonal anti C3b and anti C3d
a. monospecific AHG reagent
b. polyspecific AHG reagent
b
Also referred to as broad spectrum coombs reagent
a. monospecific AHG reagent
b. polyspecific AHG reagent
b
method of preparation in polyspecific AHG reagents
conventional/classic method (hyper immunization of rabbit)
contains only one antibody specificity
a. monospecific AHG reagent
b. polyspecific AHG reagent
a
can either be Anti-IgG, Anti-C3b or C3d
a. monospecific AHG reagent
b. polyspecific AHG reagent
a
METHOD of preparation in monospecific AHG reagents
hybridoma method (KOHLER and MILSTEIN technique)
hybridoma cell is made up of
mouse plasma cell AND myeloma cell
first stage in Ag-Ab reaction
sensitization
it occurs when antibodies react with antigens on the cells and coat the cells
sensitization
antigen binding fragment
Fab
determinant, reacts with antibody
epitope
second stage in Ag-Ab interaction
agglutination
it occurs when abs on coated cells form cross-linkages between cells resulting in visible clumping
agglutination
cross linking of Abs adjacent to antigen
lattice formation
single most important serologic test to diagnose HDFN
DAT
detects in vivo sensitization of red cells with IgG and/or complement
DAT
Investigation of transfusion reactions
a. IAT
b. DAT
b
diagnosis of autoimmune and drug-induced hemolytic anemias
a. IAT
b. DAT
b
cells used for DAT should be collected into either ———— to minimize the possibility of ——- attachment of complement components
EDTA or citrate containing anticoagulant
IN VITRO
the ———— is needed to demonstrate antibodies in the event of in vivo erythrocyte sensitization
DAT
a two-step procedure that determines in vitro sensitization of red cells
a. IAT
b. DAT
a
in IAT, what are the two procedures involved
sensitization (incubation/thermophase)
agglutination (AHG step)
incubation/thermophase
a. agglutination
b. sensitization
b
AHG step
a. agglutination
b. sensitization
a
detection of incomplete antibodies in compatibility testing or to screening cells in antibody
a. DAT
b. IAT
b
identification of antigen specificity, using a panel of red cells
a. DAT
b. IAT
b
determination of red cell phenotype using known antisera (Du testing)
a. DAT
b. IAT
b